Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine.

Vander Borght, Thierry;Laloux, Patrice;Maes, Andrée;Salmon, E;Goldman, S.;et.al.
(2001) Acta Neurologica Belgica — Vol. 101, n° 4, p. 196-209 (2001)

Files

9068.pdf
  • Restricted Access
  • Adobe PDF
  • 10.28 MB
Request a copy

Details

Authors
Show more
Abstract
The purpose of these guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of brain perfusion SPECT studies using Tc-99m radiopharmaceuticals and brain metabolism PET studies using F-18 fluorodeoxyglucose (FDG). These guidelines have been adapted and extended from those produced by the Society of Nuclear Medicine (Juni et al., 1998) and the European Association of Nuclear Medicine by a Belgian group of experts in the field trained in neurology and/or nuclear medicine. Some indications are not universally approved (e.g. brain death), but largely supported by the literature. They have been included in these guidelines in order to provide recommendations and a standardised protocol.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Vander Borght, T., Laloux, P., Maes, A., Salmon, E., Goethals, I., & Goldman, S. (2001). Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine. Acta Neurologica Belgica, 101(4), 196-209. https://hdl.handle.net/2078.5/131474 (Original work published 2001)